Skip to content

Tournament recap ·

PMPT #12 , Mega Rising Finale

7 rounds Swiss + single-elimination top cut

412 Players
80 Archetypes
$100 USD Prize pool
iLazy_B0y Winner

Four hundred twelve players and 80 different archetypes assembled for PMPT #12, the Mega Rising Finale. This event came with a twist: winners earned both the title and research materials to sharpen their game. Seven rounds of Swiss set the table for single-elimination drama.

Top 8

#PlayerDeckRecord
1 iLazy_B0y Magnezone Oricorio 12-1-1
2 CreamyLotion Suicune ex Greninja ex 11-2-1
3 yayyare Suicune ex Greninja ex 10-3-0
4 1CoolBro Magnezone Oricorio 10-3-0
5 iluchien Mega Altaria ex Indeedee ex 10-2-0
6 FrogEX | Numatinale Mega Altaria ex Greninja 9-3-0
7 WhatTheSigma Greninja Mega Absol ex 9-3-0
8 Seiren Suicune ex Greninja ex 9-3-0

iLazy_B0y claimed the title with Magnezone Oricorio, an uncommon first-place finish for the archetype. The top eight placed Suicune ex Greninja ex (three pilots), while Mega Altaria variants and another Magnezone Oricorio pilot rounded out the cut. CreamyLotion and yayyare split second and third place with Suicune ex Greninja ex, posting 11-2-1 and 10-3 records respectively.

The meta

DeckPilotsField shareWin rate
Suicune ex Greninja ex 75 48.9%
Greninja Mega Absol ex 44 50.4%
Hydreigon Mega Absol ex 34 43%
Mega Altaria ex Indeedee ex 34 48.4%
Magnezone Oricorio 33 60.4%
Decidueye ex Decidueye 30 56.9%
Mega Blaziken ex Heatmor 19 49%
Mega Altaria ex Greninja 15 42.9%
Mega Altaria ex Altaria 14 55.4%
Mega Absol ex Dusknoir 12 52.5%

Suicune ex Greninja ex remained the most-played deck in the field deck at 18.2%, but Magnezone Oricorio was the standout result with 60.4% win rate, the highest mark in the meta. Decidueye ex Decidueye also performed well at 56.9%. On the flip side, Hydreigon Mega Absol ex and Mega Altaria ex Greninja both struggled, posting 43% and 42.9% win rates from significant play volume.

Well played, iLazy_B0y! See the app for full decklists and standings, and come back for next week's event.